Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open, One-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of T00660AA for the Treatment of Endometriosis Over 52 Weeks (Follow-up to Study 307041)

NCT00225186 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00225186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00225186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open, One-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of T00660AA for the Treatment of Endometriosis Over 52 Weeks (Follow-up to Study 307041)
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
March 31, 2008
Enrollment
168 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis